Related Experiment Videos
Insights into the pharmacokinetics and pharmacodynamics of irinotecan
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.
Clinical pharmacology and therapeutics·2017
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.
Clinical pharmacology and therapeutics·2017
Food Effect Studies for Oncology Drug Products.
Clinical pharmacology and therapeutics·2017
Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program.
Clinical pharmacology and therapeutics·2016
ABC transporter polymorphisms are associated with irinotecan pharmacokinetics and neutropenia.
The pharmacogenomics journal·2016
Developing Effective, Evidence-Based Training for Cancer Team Science Leadership for National Impact.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
The Next Frontier in Quantitative Co-Clinical Imaging to Advance Functional Precision Oncology.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Safety and Efficacy of Ceralasertib plus Olaparib for Advanced/Metastatic Triple-Negative Breast Cancer in Three Molecular Strata: The Phase II VIOLETTE Study.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Evaluation of MET Detection Methods and Cutoffs in EGFR-Mutated Non-small Cell Lung Cancer Following Disease Progression on Osimertinib in the phase II SAVANNAH study.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Beyond Major Pathologic Response in Lung Cancer: Biomarkers Predict Outcomes.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Amivantamab plus pembrolizumab in previously untreated recurrent/metastatic head and neck squamous cell cancer: Results from the phase 1b/2 OrigAMI-4 study.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026